Porto Seguro
S.A.

Earnings Analysis — Last 4 Quarters

Porto (formerly Porto Seguro) has now strung together five consecutive quarters of double-digit recurring profit growth, driven less by its legacy auto book and more by the maturing Health, Bank and Services verticals. The four-quarter window below isolates that handover.

1.1Quarter-by-quarter snapshot

*Recurring net income. Headline 1T26 accounting profit was R$ 1.134bn (+36.3% YoY), inflated by a one-off ISAR-incorporation tax credit excluded from the recurring line. Sources: InfoMoney, Money Times, Genial Investimentos, Investing.com.

1.2Beat / miss detail vs. consensus

1.3Revenue & margin trajectory

1.4Quarter-defining events — the story behind the numbers

1.5Recurring earnings patterns

1.6Key metrics the market monitors

1.7What to watch — 2T26 (Aug 7, 2026)

Institutional Analysis

Porto is no longer a pure auto insurer; it is a financial ecosystem — insurance, health, a digital bank and services — distributed through Brazil's largest independent broker network. That broker channel is the moat the market keeps underwriting.

2.1Business model & revenue architecture (FY2025)

The architecture matters because it changes what kind of company PSSA3 is. For most of its history Porto was valued as a Brazilian auto insurer — a cyclical, weather- and pricing-exposed underwriter whose earnings rose and fell with loss ratios and reserve adequacy. The de-facto holding structure that has emerged over the last three years is different: a financial-services group where the lower-margin, slower-growing auto book funds customer acquisition and brand, while three faster, higher-incremental-ROE verticals (Health, Bank, Services) capture an expanding share of the same client's wallet. The strategic logic is a flywheel — the broker sells an auto policy, the relationship opens the door to a health plan, a credit card, a consortium quota and an assistance package, and each additional product both raises lifetime value and deepens the switching cost. The 1T26 disclosure that non-insurance verticals reached ~51% of group profit is the clearest evidence yet that the flywheel is turning under its own momentum rather than being pushed by a single strong quarter. The investment question is therefore less "where are auto loss ratios heading" and more "can Porto keep converting its distribution advantage into high-ROE non-insurance earnings faster than auto economics erode."

2.2Competitive moat assessment

The single pillar that justifies the premium-to-peers narrative is distribution. Porto's independent broker network is the largest of its kind in Brazil, and it is the asset that direct-to-consumer and insurtech challengers have repeatedly failed to replicate at scale. Brokers are not merely a sales channel; they are a trust intermediary in a market where consumers are wary of fine print and claims disputes, and they are the mechanism through which Porto cross-sells across verticals without the customer-acquisition cost that a pure digital bank or health plan would bear. That advantage is real but not permanent — the secular risk is that pricing transparency and aggregator platforms gradually commoditise the auto purchase, weakening the broker's gatekeeping role in the highest-volume product. PGS rates the broader moat as wide-but-narrowing in auto and widening in the ecosystem: the more of a client's financial life Porto captures, the harder that client is to dislodge on price alone, which is precisely why management's cross-sell and high-ROE-mix strategy is also a defensive one.

2.3Top 3 risks

2.4Long-term growth architecture (3–5 yr)

2.5Bull case vs. bear case

2.6Valuation context

The valuation tension is the crux of the entire case. On a standalone basis the multiple looks undemanding: a high-ROE, double-digit grower trading near 8.5x trailing earnings and ~2.0x book, with a PEG below 1, would normally screen as cheap. The reason the multiple has not expanded further — and the reason three major houses cut to neutral in H1-2026 — is twofold. First, the re-rating already happened: the shares roughly doubled over the prior two-year window, pulling the P/E up from the high-single-digits toward the low-double-digits on forward estimates, so the gap between price and intrinsic quality has substantially closed. Second, the components of the recent earnings beat are partly non-repeatable — a benign auto-loss environment, an outsized financial result in mid-2025, and a one-off tax credit in 1T26 — which makes the Street cautious about extrapolating the growth rate that drives the low PEG. Against the historical 7–13x P/E band, PSSA3 today sits in the lower-middle: cheap enough that downside is cushioned, but not so cheap that a re-rating is the base case. The dividend yield near 6% provides a floor of total return, though it is below the best dedicated B3 dividend payers, so the stock is better understood as a quality-compounder held for earnings growth than as a pure income vehicle.

2.7Analyst landscape

Consensus across ~11 covering analysts: average 12-month target R$ 55.09, high R$ 65–67, low R$ 45–46 — roughly +13% upside to the average from the price at analysis. The clear story of the last six months is a wave of downgrades to neutral after the 2024–25 rally, even from houses that still like the company.

Analyst names and targets cited only where publicly reported (Seu Dinheiro, Money Times, Investing.com, Genial, Empiricus, Nord). BTG's R$45 target dates to its early-2025 downgrade and may not reflect the latest revision.

PGS Verdict